Skip to main content

Find Clinical Trials

Home
Conditions
Secondary Hyperparathyroidism

Clinical trial condition

Secondary Hyperparathyroidism

Explore clinical trials studying Secondary Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

99 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Secondary Hyperparathyroidism trial results

Completed

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

NCT01341782

Conditions: Endocrine System Diseases, Hemodialysis, Hyperparathyroidism, +3 more
Locations: Site Reference ID/Investigator# 53485 Aichi, Japan

Site Reference ID/Investigator# 51571 Chiba, Japan

Site Reference ID/Investigator# 52963 Chiba, Japan

Site Reference ID/Investigator# 52966 Chiba, Japan

View all 45 locations

View Trial Details

Completed

SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism

NCT00117052

Conditions: Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations: Not specified

View Trial Details

Completed

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

NCT00042432

Conditions: Chronic Disease, Chronic Renal Insufficiency, Disease Attributes, +15 more
Locations: Not specified

View Trial Details

Completed

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

NCT00042653

Conditions: Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations: Not specified

View Trial Details

Completed

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

NCT00037635

Conditions: Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations: Not specified

View Trial Details

Completed

A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)

NCT00431496

Conditions: Anemia, Endocrine System Diseases, Hematologic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

NCT01083186

Conditions: Chronic Disease, Chronic Kidney Failure, Disease Attributes, +16 more
Locations: Site Reference ID/Investigator# 47002 Arta, Greece

Site Reference ID/Investigator# 43772 Athens, Greece

Site Reference ID/Investigator# 27492 Athens, Greece

Site Reference ID/Investigator# 43769 Athens, Greece

View all 24 locations

View Trial Details

Completed

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism

NCT01220050

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +3 more
Locations: Mario Negri Institute - Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy

View Trial Details

Completed

Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation

NCT01741064

Conditions: Cardiovascular Diseases, Disorder Related to Renal Transplantation, Endocrine System Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

NCT00977080

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +16 more
Locations: Site Reference ID/Investigator# 22781 Tempe, Arizona, United States

Site Reference ID/Investigator# 24342 Chula Vista, California, United States

Site Reference ID/Investigator# 21142 Los Angeles, California, United States

Site Reference ID/Investigator# 22762 Los Angeles, California, United States

View all 83 locations

View Trial Details